Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 512.5	$ 542.8
Accounts receivable, less allowance for doubtful accounts	1,150.8	1,275.8
Inventories	2,362.3	2,256.5
Prepaid expenses and other current assets	375.9	352.3
Total Current Assets	4,401.5	4,427.4
Property, plant and equipment, net	2,055.3	2,015.4
Goodwill	9,544.9	9,594.4
Intangible assets, net	7,339.9	7,684.6
Other assets	973.6	405.0
Total Assets	24,315.2	24,126.8
Current Liabilities:
Accounts payable	355.2	362.6
Income taxes payable	100.1	142.4
Other current liabilities	1,318.6	1,391.3
Current portion of long-term debt	2,000.0	525.0
Total Current Liabilities	3,773.9	2,421.3
Deferred income taxes, net	912.2	999.5
Long-term income tax payable	680.9	666.2
Other long-term liabilities	516.8	350.0
Long-term debt	6,345.9	8,413.7
Total Liabilities	12,229.7	12,850.7
Commitments and Contingencies (Note 17)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 309.5 million shares in 2019 (307.9 million in 2018) issued	3.1	3.1
Paid-in capital	8,867.2	8,686.1
Retained earnings	10,155.3	9,491.2
Accumulated other comprehensive loss	(223.2)	(187.4)
Treasury stock, 103.9 million shares in 2019 (103.9 million shares in 2018)	(6,720.9)	(6,721.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,081.5	11,271.3
Noncontrolling interest	4.0	4.8
Total Stockholders' Equity	12,085.5	11,276.1
Total Liabilities and Stockholders' Equity	$ 24,315.2	$ 24,126.8